About Robert W Huigens, III
Robert Huigens received his bachelors in Biology from the University of North Carolina at Greensboro in 2003. He then pursued graduate studies in Chemistry at North Carolina State University under the direction of Professor Christian Melander. After earning his Ph.D. in 2009, he went on to become an American Cancer Society postdoctoral fellow at the University of Illinois at Urbana-Champaign under the guidance of Professor Paul Hergenrother. In 2013, Dr. Huigens joined the Medicinal Chemistry Department at the University of Florida as an assistant professor. His research interests include organic synthesis, drug discovery, medicinal chemistry, chemical biology, antibacterial agents and personalized cancer therapeutics. Recently, Dr. Huigens was the recipient of two Young Investigator Awards from the American Chemical Society (Division of Medicinal Chemistry) and the Center for Biofilm Engineering (Montana State University) for his group’s discovery of novel bacterial biofilm-eradicating agents.
The overarching goal of the Huigens lab is to push back the boundaries of drug discovery using new and innovative strategies to tackle unmet challenges associated with complex molecule synthesis, drug-resistant bacteria and cancer. Students and postdocs in our group receive training at the interface of chemistry and biology using a combination of synthetic organic chemistry, medicinal chemistry, chemical biology and microbiology approaches. We currently have three major areas of research: Discovery of Antibacterial & Biofilm-Eradicating Agents, Ring Distortion of Complex Natural Products and Thymidylate Synthase Inhibitors as Anticancer Agents.